Last Updated: August 3, 2026

BETOPTIC PILO Drug Patent Profile

✉ Email this page to a colleague

When do Betoptic Pilo patents expire, and when can generic versions of Betoptic Pilo launch?

Betoptic Pilo is a drug marketed by Alcon and is included in one NDA.

The generic ingredient in BETOPTIC PILO is betaxolol hydrochloride; pilocarpine hydrochloride. There are eleven drug master file entries for this compound. Additional details are available on the betaxolol hydrochloride; pilocarpine hydrochloride profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for BETOPTIC PILO?
What are the global sales for BETOPTIC PILO?
What is Average Wholesale Price for BETOPTIC PILO?

Summary for BETOPTIC PILO

US Patents:	0
Applicants:	1
NDAs:	1

US Patents and Regulatory Information for BETOPTIC PILO

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alcon	BETOPTIC PILO	betaxolol hydrochloride; pilocarpine hydrochloride	SUSPENSION/DROPS;OPHTHALMIC	020619-001	Apr 17, 1997		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for BETOPTIC PILO

See the table below for patents covering BETOPTIC PILO around the world.

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
Australia	1607495		⤷ Start Trial
Australia	4575389		⤷ Start Trial
Australia	621692		⤷ Start Trial
Australia	688854		⤷ Start Trial
Canada	2004468	GOUTTES LUBRIFIANTES A LIBERATION SOUTENUE POUR LE TRAITEMENT DU GLAUCOME (SUSTAINED RELEASE, COMFORT FORMULATION FOR GLAUCOMA THERAPY)	⤷ Start Trial
Canada	2181929	COMPOSITIONS DE TRAITEMENT DU GLAUCOME COMPRENANT DE LA PILOCARPINE ET UN BETA-BLOQUANT (COMPOSITIONS FOR TREATMENT OF GLAUCOMA COMPRISING PILOCARPINE AND A BETA-BLOCKER)	⤷ Start Trial
Germany	68913979		⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.